Interestingly, we found that RXRA is quickly down-regulated at the protein level, via 26S proteasome-dependent pathways, similar to that reported for two other synthetic RXRA agonists [36] while increasing the levels of the PPARG protein, and is potentially relevant to a recent study showing reduction of RXRA mRNA in breast cancer cells [44]. Here, RXRA is linked to breast carcinoma.